Due to the complexity of their products (immune-oncology, medical device – drug combination,
predictive medicine, genomic biobank, …), Biotech companies heavily relied on SMEs with a
grasp of the requirements and obligations required to support the technology initiation,
development, and management of clinical trials.
At Kuwa Consulting Group, our life sciences consultants have engaged in multicentric clinical
studies spanning several countries and are adept in various dialects and languages to support
our client’s professional delivery accounting for the cultural environment in which they
operate. We are committed to supporting all phases of our client’s product delivery inclusive of
transition from R&D to Clinical.